Klin Farmakol Farm. 2006;20(1):41-42

Peripheral neuropathy as an advarse effect of statins

MUDr. Pavel Otruba, prof. MUDr. Petr Kaňovský CSc
Neurologická klinika FN a LF UP Olomouc

Lipid-lowering agents rank among the most widely used medications. Numerous studies have demonstrated their significant benefit in the prevention of cardiovascular diseases. Adverse effects in the form of muscular affections have been well described. Recently observations have been made which suggest the possible risk of peripheral neuropathy in patients treated for a long term with lipid-lowering drugs. The aim of this article is to bring these effects to our attention and point to possible prevention through sensible pharmacotherapy.

Keywords: statins, myopathy, polyneuropathy

Published: March 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Otruba P, Kaňovský P. Peripheral neuropathy as an advarse effect of statins. Klin Farmakol Farm. 2006;20(1):41-42.
Download citation

References

  1. Moosmann B, Behl C. Selenoprotein synthesis and side-effects of statins. Lancet 2004; 363: 892-894. Go to original source... Go to PubMed...
  2. MRC/BHF Heart Protection Study of cholesterol lowering with Simvastatine in 20,536 high-risk individuals: a randomised placebo controlled trail. Lancet 2002; 360: 7-22.
  3. Jacobs MB. HMG-CoA reductase inhibitor therapy and peripheral neuropathy. Ann Intern Med 1994; 120: 970. Go to original source... Go to PubMed...
  4. Silveberg C. Atorvastatin-induced polyneuropathy. Ann Intern Med 2003; 139: 792-793. Go to original source... Go to PubMed...
  5. Gaist D, Garcia Rodriguez LA, Huerta C, Hallas J, Sindrup SH. Are users of lipid-lowering drugs at increased risk of peripheral neuropathy? Eur J Clin Pharmacol. 2001; 56: 931-933. Go to original source... Go to PubMed...
  6. Gaist D, Jeppesen U, Andersen M, García Rodríguez LA, Hallas J, Sindrup SH. Statins and risk of polyneuropathy: A case-control study. Neurology 2002; 58: 1333-1337. Go to original source... Go to PubMed...
  7. Corrao G, Zambon A, Bertu L, Botteri E, Leoni O, Contiero P. Lipid lowering drugs prescription and the risk of peripheral neuropathy: an exploratory case-control study using automated databases. J Epidemiol Community Health. 2004; 58 (12): 1047-1051. Go to original source... Go to PubMed...
  8. Lo YL, Leoh TH, Loh LM, Tan CE. Statin therapy and small fibre neuropathy: a serial electrophysiological study. J Neurol Sci. 2003; 208: 105-108. Go to original source... Go to PubMed...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.